Evidence map›Paper›PMID 38812107›Full record

ArticleJournal of applied clinical medical physics2024

Clinical evaluation of deep learning-enhanced lymphoma pet imaging with accelerated acquisition.

Xu Li, Boyang Pan, Congxia Chen, Dongyue Yan, Zhenglin Pan, Tao Feng, Hui Liu, Nan-Jie Gong, Fugeng Liu

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Clinical validation of a deep learning model for low-count PET image enhancement.European journal of nuclear medicine and molecular imaging · 2025
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xu LiDepartment of Nuclear Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Boyang PanRadioDynamic Healthcare, Shanghai, People's Republic of China.ORCID https://orcid.org/0009-0006-0258-0346
Congxia ChenDepartment of Nuclear Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Dongyue YanDepartment of Nuclear Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Zhenglin PanRadioDynamic Healthcare, Shanghai, People's Republic of China.
Tao FengLaboratory for Intelligent Medical Imaging, Tsinghua Cross-strait Research Institute, Beijing, People's Republic of China.
Hui LiuDepartment of Engineering Physics, Tsinghua University, Beijing, People's Republic of China.
Nan-Jie GongLaboratory for Intelligent Medical Imaging, Tsinghua Cross-strait Research Institute, Beijing, People's Republic of China.
Fugeng LiuDepartment of Nuclear Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aims to evaluate the clinical performance of a deep learning (DL)-enhanced two-fold accelerated PET imaging method in patients with lymphoma.

methodsA total of 123 cases devoid of lymphoma underwent whole-body 18F-FDG-PET/CT scans to facilitate the development of an advanced SAU2Net model, which combines the advantages of U2Net and attention mechanism. This model integrated inputs from simulated 1/2-dose (0.07 mCi/kg) PET acquisition across multiple slices to generate an estimated standard dose (0.14 mCi/kg) PET scan. Additional 39 cases with confirmed lymphoma pathology were utilized to evaluate the model's clinical performance. Assessment criteria encompassed peak-signal-to-noise ratio (PSNR), structural similarity index (SSIM), a 5-point Likert scale rated by two experienced physicians, SUV features, image noise in the liver, and contrast-to-noise ratio (CNR). Diagnostic outcomes, including lesion numbers and Deauville score, were also compared.

resultsImages enhanced by the proposed DL method exhibited superior image quality (P < 0.001) in comparison to low-dose acquisition. Moreover, they illustrated equivalent image quality in terms of subjective image analysis and lesion maximum standardized uptake value (SUVmax) as compared to the standard acquisition method. A linear regression model with y = 1.017x + 0.110 (

conclusionThe proposed DL method could facilitate a 50% reduction in PET imaging duration for lymphoma patients, while concurrently preserving image quality and diagnostic accuracy.

Indexed as

Deep LearningFluorodeoxyglucose F18Image Processing, Computer-AssistedLymphomaPositron Emission Tomography Computed TomographyRadiopharmaceuticalsSignal-To-Noise RatioAdultAgedAged, 80 and overFemaleHumansImage Interpretation, Computer-AssistedMaleMiddle AgedPrognosisFluorodeoxyglucose F18Radiopharmaceuticalsdeep learninglow‐dose imaginglymphomaPET

Identifiers

PMID38812107
PMCPMC11492391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.